Tenofovir Alafenamide Tablet, Film-coated Tanzanie - anglais - Tanzania Medicinces & Medical Devices Authority

tenofovir alafenamide tablet, film-coated

laurus labs limited, india - tenofovir alafenamide - tablet, film-coated - 25 mg

Darunavir and Ritonavir Tablets 800/100 Tanzanie - anglais - Tanzania Medicinces & Medical Devices Authority

darunavir and ritonavir tablets 800/100

hetero laboratories limited, india - darunavir , ritonavir tablets 800mg/100mg - tablets - 800/100

Dolutegravir Tablets 50mg Oral tablet Tanzanie - anglais - Tanzania Medicinces & Medical Devices Authority

dolutegravir tablets 50mg oral tablet

hetero laboratories limited, india - dolutegravir tablets 50mg - oral tablet - 50

RANITIDINE 150 MG- ranitidine tablet, film coated 
RANITIDINE 300 MG- ranitidine tablet, film coated États-Unis - anglais - NLM (National Library of Medicine)

ranitidine 150 mg- ranitidine tablet, film coated ranitidine 300 mg- ranitidine tablet, film coated

vivimed labs limited - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine tablets, usp is indicated in: 1. short – term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo–controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger–ellision syndrome and systemic mastocytosis). 4. short–term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo–controlled studies have been

Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate Tablets 50mg/300mg/300mg Oral tablet 50/300/300 Tanzanie - anglais - Tanzania Medicinces & Medical Devices Authority

dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets 50mg/300mg/300mg oral tablet 50/300/300

hetero laboratories limited, india - dolutegravir, lamivudine , tenofovir disoproxil fumarate tablets 50mg/300mg/300mg - oral tablet - 50/300/300

Esaote MyLabSix Ultrasound System Singapour - anglais - HSA (Health Sciences Authority)

esaote mylabsix ultrasound system

emergo singapore consulting private limited - radiology / imaging - esaote’s mylabsix ultrasound system is a mainframe ultrasound system used to perform diagnostic ultrasound studies including cardiac, transesophageal cardiac, peripheral vascular, neonatal cephalic, adult cephalic, small organs, musculoskeletal (conventional and superficial), abdominal, fetal, transvaginal, transrectal, pediatric and other: urologic. the system provides imaging for guidance of biopsy and imaging to assist in the placement of needles in vascular or other anatomical structures as well as peripheral nerve blocks in musculo-skeletal applications.

TRIAMCINOLONE ACETONIDE lotion États-Unis - anglais - NLM (National Library of Medicine)

triamcinolone acetonide lotion

micro labs limited - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide lotion, 0.1% is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

CLOBETASOL PROPIONATE solution États-Unis - anglais - NLM (National Library of Medicine)

clobetasol propionate solution

micro labs limited - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate topical solution, usp is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp. treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 ml/week because of the potential for the drug to suppress the hpa axis. this product is not recommended for use in pediatric patients under 12 years of age.  clobetasol propionate topical solution is contraindicated in patients with primary infections of the scalp, or in patients who are hypersensitive to clobetasol propionate, other corticosteroids, or any ingredient in this preparation.

LOSARTAN POTASSIUM tablet, film coated États-Unis - anglais - NLM (National Library of Medicine)

losartan potassium tablet, film coated

micro labs limited - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 25 mg - losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarction. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including losartan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive

TELMISARTAN- telmisartan tablet États-Unis - anglais - NLM (National Library of Medicine)

telmisartan- telmisartan tablet

micro labs limited - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq) - telmisartan 20 mg - telmisartan tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of